Lyra Therapeutics (LYRA) Appoints Jim Tobin to its Board

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. AMGN
3. BKNG
4. DOX
5. ANET
6. DUOL
7. XYZ
8. SWKS
9. FISV
10. CVS

Go back to Lyra Therapeutics (LYRA) Appoints Jim Tobin to its Board

Lyra Therapeutics Appoints Jim Tobin to Board of Directors

March 7, 2022 7:00 AM EST

WATERTOWN, Mass., March 7, 2022 /PRNewswire/ -- Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company leveraging its proprietary XTreo platform to enable precise, sustained, and local delivery of medications to the ear, nose and throat (ENT) passages and other diseased tissues, today announced the appointment of Jim Tobin to its Board of Directors (BOD). The former President and Chief Executive Officer of both Boston Scientific Corporation and Biogen Inc., Mr. Tobin currently serves as Chairman of the Board at TransMedics, Inc. and Board Member of each of Globus Medical Inc., a... More